2017-03-24,Shark Bites: Even Without Health Care Vote, Market's Feeling Better
2017-03-07,Supernus Announces Settlement With Actavis On Trokendi XR® Patent Litigation
2017-03-06,Supernus Announces Settlement With Zydus On Trokendi XR® Patent Litigation
2017-03-01,4 Smaller Biotech Names Worth Researching
2017-02-28,Supernus Announces Record Fourth Quarter And Full Year 2016 Financial Results
2017-02-27,Supernus To Present At Cowen Health Care Conference In March
2017-02-13,Supernus To Host Fourth Quarter And Full Year 2016 Earnings Conference Call
2017-02-08,Supernus Announces Issuance Of Eighth U.S. Patent Protecting Trokendi XR®
2017-01-30,Supernus Announces Issuance Of Seventh U.S. Patent Protecting Trokendi XR®
2017-01-23,Supernus Files Form 10-Q For Third Quarter 2016 And Is Now Current With All Financial Filings
2017-01-11,4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)
2017-01-03,Supernus To Present At The 2017 J.P. Morgan Healthcare Conference
2016-12-20,The Bulls Don't Have Enough Juice for 20,000
2016-12-20,Rev's Forum: Can the Market Find a Second Wind?
2016-12-19,Big-Cap Tech Names, Biotechs, Oils Lifting Market
2016-12-12,Supernus Wins Appeal Case On Oxtellar XR®
2016-11-17,Supernus Receives Nasdaq Non-Compliance Notice
2016-11-14,Supernus Provides Business Update
2016-11-12,'Mad Money' Lightning Round: 'Health Care Is All Over the Map'
2016-11-11,Jim Cramer's 'Mad Money' Recap: Markets Pivot From Shocked to Bullish
2016-11-11,Supernus To Host A Business Update Call
2016-11-07,Supernus To Present At Three November Healthcare Conferences
2016-11-03,Supernus Pharmaceuticals (SUPN) Shares Cross Below 200 DMA
2016-11-03,Relative Strength Alert For Supernus Pharmaceuticals
2016-11-01,Small Biotechs on My Shopping List
2016-10-13,Supernus Offers Super Small-Cap Potential
2016-10-11,Supernus Announces Positive Results From Phase IIb Clinical Trial For SPN-812 In Children With ADHD
2016-10-10,Supernus Schedules Conference Call To Present Results Of Phase IIb Clinical Trial Of SPN-812 In Children With ADHD
2016-09-23,A Pullback Drops Major Indices
2016-09-19,Seeing the Same Old Patterns Ahead of Fed News
2016-09-16,Shark Bites: 5 Stocks I Am Playing in This Choppy Action
2016-08-19,Supernus Receives FDA Tentative Approval For Expanded Label Of Trokendi XR® To Include Migraine Prophylaxis In Adults
2016-08-12,Supernus Announces Resignation Of Dr. James Barrett From Board Of Directors; Charles W. Newhall, III Elected Chairman
2016-08-03,Supernus Pharmaceuticals (SUPN) Reaches New Lifetime High Today
2016-08-02,Supernus Announces Second Quarter 2016 Financial Results
2016-07-27,Supernus Pharmaceuticals (SUPN) Is Today's Strong And Under The Radar Stock
2016-07-20,Supernus To Host Second Quarter 2016 Earnings Conference Call
2016-07-12,Today's Strong And Under The Radar Stock Is Supernus Pharmaceuticals (SUPN)
2016-07-12,Supernus Pharmaceuticals Founder And CEO Jack Khattar Joins ScPharmaceuticals Board Of Directors
2016-07-07,Supernus Pharmaceuticals (SUPN) Is Today's Perilous Reversal Stock
2016-06-22,Supernus Announces Issuance Of Seventh U.S. Patent Protecting Oxtellar XR®
2016-06-17,Supernus Pharmaceuticals (SUPN): Today's Weak On High Volume Stock
2016-06-16,Supernus Provides Update On Trokendi XR® Migraine SNDA And Reiterates Guidance
2016-06-02,Supernus Announces Issuance Of Sixth U.S. Patent Protecting Oxtellar XR®
2016-06-01,Commit To Purchase Supernus Pharmaceuticals At $15, Earn 13.5% Annualized Using Options
2016-05-24,Supernus To Present At June Jefferies Healthcare Conference
2016-05-10,Supernus Enters Into Partial Settlement Agreement With Actavis On Oxtellar XR®
2016-05-04,Supernus Pharmaceuticals (SUPN) Shares Cross Below 200 DMA
2016-05-03,Supernus Announces First Quarter 2016 Financial Results
2016-04-19,Supernus To Host First Quarter 2016 Earnings Conference Call
2016-04-01,SUPN Crosses Above Key Moving Average Level
2016-03-30,Ratings Changes Today
2016-03-10,Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)
2016-03-02,Supernus Announces Record Fourth Quarter And Full Year 2015 Financial Results
2016-03-01,First Week of SUPN April 15th Options Trading
2016-02-25,Supernus To Present At March Cowen Health Care Conference
2016-02-18,Supernus To Host Fourth Quarter And Full Year 2015 Earnings Conference Call
2016-02-08,Supernus Prevails In Oxtellar XR® ANDA Litigation
2016-01-29,Strong On High Relative Volume: Supernus Pharmaceuticals (SUPN)
2016-01-22,First Week of September 16th Options Trading For Supernus Pharmaceuticals (SUPN)
2016-01-08,Supernus Pharmaceuticals is Now Oversold (SUPN)
2015-12-14,Oversold Conditions For Supernus Pharmaceuticals (SUPN)
2015-12-04,Supernus Announces Distribution Of Common Stock By NEA
2015-12-02,Supernus To Attend Guggenheim Securities Boston Healthcare Conference
2015-11-13,Today's Dead Cat Bounce Stock Is Supernus Pharmaceuticals (SUPN)
2015-11-12,Supernus Announces Distribution Of Common Stock By NEA
2015-11-09,Supernus To Present At Two Investor Conferences
2015-11-09,Insider Trading Alert - MXL, SCOR And SUPN Traded By Insiders
2015-11-03,Supernus Announces Third Quarter 2015 Financial Results And Raises 2015 Guidance
2015-10-22,Supernus Announces FDA Acceptance Of SNDA To Add Migraine To Trokendi XR(R) Label
2015-10-21,First Week Of SUPN June 2016 Options Trading
2015-10-20,Supernus To Host Third Quarter 2015 Earnings Conference Call
2015-10-20,Perilous Reversal Stock: Supernus Pharmaceuticals (SUPN)
2015-10-15,Supernus Pharmaceuticals (SUPN) Strong On High Relative Volume Today
2015-10-15,Supernus Announces Settlement With Par On Trokendi XR(R) Patent Litigation
2015-09-29,Notable Two Hundred Day Moving Average Cross - SUPN
2015-09-28,Supernus Pharmaceuticals is Now Oversold (SUPN)
2015-09-22,Supernus Pharmaceuticals (SUPN) Showing Signs Of A Dead Cat Bounce Today
2015-09-10,Today's Dead Cat Bounce Stock Is Supernus Pharmaceuticals (SUPN)
2015-09-02,Supernus Announces Issuance Of Fifth U.S. Patent Protecting Oxtellar XR(R)
2015-08-28,Interesting SUPN Put And Call Options For October 16th
2015-08-27,Supernus To Attend FBR Healthcare Conference On September 9th
2015-08-19,Trade-Ideas: Supernus Pharmaceuticals (SUPN) Is Today's "Dead Cat Bounce" Stock
2015-08-18,Today's Perilous Reversal Stock: Supernus Pharmaceuticals (SUPN)
2015-08-06,Trade-Ideas: Supernus Pharmaceuticals (SUPN) Is Today's "Dead Cat Bounce" Stock
2015-08-05,New Lifetime High Reached By Supernus Pharmaceuticals (SUPN)
2015-08-04,Supernus Announces Second Quarter 2015 Financial Results
2015-07-28,New Lifetime High For Supernus Pharmaceuticals (SUPN)
2015-07-21,First Week Of March 2016 Options Trading For Supernus Pharmaceuticals (SUPN)
2015-07-20,Supernus To Host Second Quarter 2015 Earnings Conference Call
2015-07-20,Supernus Pharmaceuticals (SUPN) Reaches New Lifetime High Today
2015-07-15,Insider Trading Alert - VHI, SNX And SUPN Traded By Insiders
2015-07-15,Insider Trading Alert - VHI, SNX And SUPN Traded By Insiders
2015-06-23,First Week Of SUPN August 21st Options Trading
2015-06-19,Perilous Reversal Stock: Supernus Pharmaceuticals (SUPN)
2015-06-18,Today's Dead Cat Bounce Stock Is Supernus Pharmaceuticals (SUPN)
2015-06-17,Supernus Corrects Earlier Statement Regarding Distribution Of Common Stock By NEA
2015-06-17,Supernus Announces Distribution Of Common Stock By NEA
2015-06-16,Insider Trading Alert - GFN, SCOR And SUPN Traded By Insiders
2015-06-15,Insider Trading Alert - ALXN, SUPN And WLDN Traded By Insiders
2015-06-12,New Lifetime High For Supernus Pharmaceuticals (SUPN)
2015-06-10,Supernus Pharmaceuticals (SUPN) Weak On High Volume Today
2015-06-08,Supernus Announces Webcast Of Investor Day On June 17, 2015
2015-06-01,Today's Weak On High Volume Stock: Supernus Pharmaceuticals (SUPN)
2015-05-19,Supernus To Present At June Jefferies Healthcare Conference
2015-05-06,Supernus Pharmaceuticals (SUPN) Weak On High Volume Today
2015-05-05,Supernus Announces First Quarter 2015 Financial Results
2015-04-21,Supernus To Host First Quarter 2015 Earnings Conference Call
2015-04-02,Supernus Announces Issuance Of Sixth U.S. Patent Protecting Trokendi XR(R)
2015-03-25,First Week Of May 15th Options Trading For Supernus Pharmaceuticals (SUPN)
2015-03-23,Georges Gemayel, Ph.D., Joins Supernus Board Of Directors
2015-03-11,Supernus Pharmaceuticals (SUPN) Stock Is Up Today on Earnings Beat
2015-03-10,Supernus Announces Fourth Quarter And Full Year 2014 Results
2015-02-18,Supernus To Present At March Cowen Conference
2015-02-17,Supernus To Host Fourth Quarter And Full Year 2014 Earnings Conference Call
2015-01-21,Supernus Sues TWi For Infringement Of Oxtellar XR(R) Patents
2015-01-16,Supernus Sues Par For Infringement Of Trokendi XR(R) Patents
2015-01-14,Supernus Pharmaceuticals (SUPN) Is Strong On High Volume Today
2015-01-13,Short Interest Makes 30.7% Move For SUPN
2015-01-06,Interesting SUPN Put And Call Options For February 20th
2014-12-10,Supernus Announces Paragraph IV ANDA Filing For Oxtellar XR(R)
2014-12-09,Supernus Announces Paragraph IV ANDA Filing For Trokendi XR(R)
2014-11-24,Supernus Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R)
2014-11-21,Supernus Sues Zydus For Infringement Of Trokendi XR(R) Patents
2014-11-11,Supernus Announces Third Quarter 2014 Results
2014-11-07,Supernus Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR(R)
2014-11-04,Supernus To Present At Two Investor Conferences
2014-10-29,Supernus To Host Third Quarter 2014 Earnings Conference Call
2014-10-14,Supernus Announces Paragraph IV ANDA Filing For Trokendi XR(R)
2014-10-02,Supernus Sues Actavis For Infringement Of Trokendi XR(R) Patents
2014-09-26,Commit To Buy Supernus Pharmaceuticals At $7, Earn 16.4% Annualized Using Options
2014-09-22,Supernus Provides Business Update
2014-09-10,Supernus Pharmaceuticals (SUPN) Is Today's Strong On High Volume Stock
2014-09-04,Supernus Announces Issuance Of Fourth US Patent Protecting Oxtellar XR(R)
2014-08-21,Supernus Announces Paragraph IV ANDA Filing For Trokendi XR(R)
2014-08-19,Supernus To Attend FBR HealthCare Conference In September
2014-08-14,Supernus Receives FDA Fast Track Designation For SPN-810
2014-08-11,Supernus Announces Second Quarter 2014 Results
2014-07-31,Supernus Pharmaceuticals Enters Oversold Territory (SUPN)
2014-07-29,Supernus To Host Second Quarter 2014 Earnings Conference Call
2014-07-24,Ratings Changes Today
2014-07-08,Supernus To Receive $30 Million In Non-Dilutive Royalty Deal
2014-06-25,Interesting SUPN Put And Call Options For August 16th
2014-05-21,Supernus To Present At Jefferies Healthcare Conference In June
2014-05-20,Supernus Receives $2 Million Milestone For United Therapeutics' Launch Of Orenitram(TM)
2014-05-20,First Week of July 19th Options Trading For Supernus Pharmaceuticals (SUPN)
2014-05-12,Supernus Announces First Quarter 2014 Results
2014-04-29,Supernus To Host First Quarter 2014 Earnings Conference Call
2014-04-15,Oversold Conditions For Supernus Pharmaceuticals (SUPN)
2014-03-17,4 Stocks Under $10 Making Big Moves
2014-03-12,Supernus Announces Fourth Quarter And Full Year 2013 Results
2014-03-12,Supernus Announces Issuance Of Third US Patent Protecting Trokendi XR&#8482;
2014-02-25,Supernus To Host Fourth Quarter And Full Year 2013 Earnings Conference Call
2014-02-20,Supernus To Present At Cowen And Company Healthcare Conference In March
2014-02-12,Short Interest Moves 13% Lower For SUPN
2014-02-07,Supernus At Citibank And RBC Global Healthcare Conferences In February
2014-02-03,Supernus Announces Publication Of Phase III Study (PROSPER) Results On Oxtellar XR&#174;
2014-01-27,Supernus Announces Issuance Of First Use Patents Protecting SPN-812 As A Novel Non-Stimulant ADHD Product
2014-01-07,Supernus Announces Issuance Of Third US Patent Protecting Oxtellar XR(R)
2013-12-24,Supernus Announces Resignation Of Board Member
2013-12-23,Supernus Announces FDA Approval Of Its Partner's Product, Orenitram(TM)
2013-12-12,Supernus Posts Exciting Clinical Data Regarding Trokendi XR(TM) And Oxtellar XR(TM) On The Company Website
2013-12-06,5 Stocks Under $10 Moving Higher
2013-11-27,Supernus Pharmaceuticals Stock Sees Short Interest Decline 11.3%
2013-11-21,Supernus To Present At Piper Jaffray Healthcare Conference In December
2013-11-12,Supernus Pharmaceuticals Reports Third Quarter 2013 Financial Results
2013-11-11,Interesting SUPN Put Options For January 2016
2013-11-08,January 2015 Options Now Available For Supernus Pharmaceuticals (SUPN)
2013-11-06,Supernus Announces Third Quarter 2013 Earnings Conference Call And Webcast
2013-11-06,Supernus Announces Release Of Exciting New Clinical Data On Trokendi XR(TM)
2013-10-22,Supernus Pharmaceuticals Is Now Oversold (SUPN)
2013-09-20,5 Biotech Stocks Under $10 on the Move
2013-09-05,Supernus Launches Trokendi XR(TM) In The United States
2013-08-29,Supernus To Present At Two Investor Conferences In September
2013-08-19,Supernus Announces Final FDA Approval And Upcoming Launch Of Trokendi XR(TM)
2013-08-13,Supernus Pharmaceuticals Reports Second Quarter 2013 Financial Results
2013-08-07,Supernus Sues Watson For Infringement Of Oxtellar XR(TM) Patents
2013-08-06,Supernus Announces Second Quarter 2013 Earnings Conference Call And Webcast
2013-07-25,Short Interest In Supernus Pharmaceuticals Increases 12.2%
2013-07-02,SUPN: Insiders Vs. Shorts
